Cefdinir Capsule
Product Images NDC 57237-099

2 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 57237-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel -300 mg (60 Capsule Bottle) (Cefdinir Fig1)

Package Label-principal Display Panel -300 mg (60 Capsule Bottle) (Cefdinir Fig1)
Label for Cefdinir Capsules, USP 300 mg by Rising Pharma Holdings, Inc., containing 60 oral capsules. The label includes dosage strength, quantity, storage instructions, distributor information, barcode, and cautions to keep out of reach of children. Manufactured in India and marked Rx only.*
FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical Structure (Cefdinir Str)
Chemical structure of Cefdinir, showing its molecular arrangement with nitrogen, sulfur, oxygen, hydrogen, and carbon atoms connected in a characteristic beta-lactam ring and side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.